VERU · Insider Trading
Veru Inc.
Every open-market purchase and sale reported by VERU officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-17 | K Gary Barnette | Chief Scientific Officer | Buy | +1,800 | +$4.84K |
| 2026-05-06 | Loren Mark Katzovitz | Director | A | +102,000 deriv. | — |
| 2026-05-06 | Lucy Lu | Director | A | +104,000 deriv. | — |
| 2026-05-06 | Grace Hyun | Director | A | +97,000 deriv. | — |
| 2026-05-06 | Harry Fisch | Chief Corporate Officer | A | +160,000 deriv. | — |
| 2026-05-06 | Michele Greco | Chief Admin Officer and CFO | A | +164,000 deriv. | — |
| 2026-05-06 | Mitchell Shuster Steiner | President and CEO | A | +604,000 deriv. | — |
| 2026-05-06 | K Gary Barnette | Chief Scientific Officer | A | +160,000 deriv. | — |
| 2026-05-06 | Michael L Rankowitz | Director | A | +100,000 deriv. | — |
| 2025-12-09 | Mitchell Shuster Steiner | President and CEO | A | +100,000 deriv. | — |
| 2025-12-09 | Michael L Rankowitz | Director | A | +3,000 deriv. | — |
| 2025-12-09 | Harry Fisch | Chief Corporate Officer | A | +27,000 deriv. | — |
| 2025-12-09 | Michele Greco | Chief Admin Officer and CFO | A | +27,000 deriv. | — |
| 2025-12-09 | Lucy Lu | Director | A | +4,000 deriv. | — |
| 2025-12-09 | K Gary Barnette | Chief Scientific Officer | A | +27,000 deriv. | — |
| 2025-12-09 | Grace Hyun | Director | A | +6,000 deriv. | — |
| 2025-12-09 | Loren Mark Katzovitz | Director | A | +6,000 deriv. | — |
| 2025-10-03 | Lucy Lu | Director | A | +6,000 deriv. | — |
| 2025-10-03 | Michael L Rankowitz | Director | A | +7,000 deriv. | — |
| 2025-10-03 | Grace Hyun | Director | A | +3,000 deriv. | — |
| 2025-05-08 | Loren Mark Katzovitz | Director | A | +90,000 deriv. | — |
| 2025-05-08 | K Gary Barnette | Chief Scientific Officer | A | +104,000 deriv. | — |
| 2025-05-08 | Michele Greco | Chief Admin Officer and CFO | A | +108,000 deriv. | — |
| 2025-05-08 | Mitchell Shuster Steiner | President and CEO | A | +378,000 deriv. | — |
| 2025-05-08 | Michael L Rankowitz | Director | A | +15,000 deriv. | — |
| 2025-05-08 | Harry Fisch | Chief Corporate Officer | A | +104,000 deriv. | — |
| 2025-05-08 | Grace Hyun | Director | A | +55,000 deriv. | — |
| 2025-05-08 | Lucy Lu | Director | A | +30,000 deriv. | — |
| 2025-03-14 | Grace Hyun | Director | A | +5,000 deriv. | — |
| 2025-03-14 | Loren Mark Katzovitz | Director | A | +10,000 deriv. | — |
| 2025-02-20 | Michael L Rankowitz | Director | Buy | +150,000 | +$84.35K |
| 2024-10-02 | Grace Hyun | Director | A | +40,000 deriv. | — |
| 2024-10-02 | Michael L Rankowitz | Director | A | +85,000 deriv. | — |
| 2024-10-02 | Mario Eisenberger | Director | A | +45,000 deriv. | — |
| 2024-10-02 | Lucy Lu | Director | A | +70,000 deriv. | — |
| 2024-08-07 | Loren Mark Katzovitz | Director | A | +80,000 deriv. | — |
| 2024-08-07 | Lucy Lu | Director | A | +20,000 deriv. | — |
| 2024-08-07 | Mario Eisenberger | Director | A | +30,000 deriv. | — |
| 2024-08-07 | Grace Hyun | Director | A | +40,000 deriv. | — |
| 2024-08-07 | Michael L Rankowitz | Director | A | +10,000 deriv. | — |
| 2024-05-28 | Harry Fisch | Chief Corporate Officer | Buy | +4,000 | +$5.00K |
| 2024-05-24 | K Gary Barnette | Chief Scientific Officer | Buy | +5,000 | +$6.70K |
| 2024-05-24 | Mitchell Shuster Steiner | President and CEO | Sell | −70,183 | −$87.53K |
| 2024-05-17 | Mitchell Shuster Steiner | President and CEO | Sell | −171,875 | −$246.93K |
| 2024-05-17 | Harry Fisch | Chief Corporate Officer | Buy | +6,711 | +$10.00K |
| 2024-05-09 | Mitchell Shuster Steiner | President and CEO | A | +376,000 deriv. | — |
| 2024-05-09 | Harry Fisch | Chief Corporate Officer | A | +102,000 deriv. | — |
| 2024-05-09 | Michele Greco | Chief Admin Officer and CFO | A | +106,000 deriv. | — |
| 2024-05-09 | K Gary Barnette | Chief Scientific Officer | A | +102,000 deriv. | — |
| 2023-11-17 | Grace Hyun | Director | A | +60,000 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Harry Fisch | Chief Corporate Officer | 801,384 | $1.77M |
| Mitchell Shuster Steiner | President and CEO | 715,039 | $1.58M |
| Michael L Rankowitz | Director | 25,000 | $55.25K |
| Michele Greco | Chief Admin Officer and CFO | 9,618 | $21.26K |
| K Gary Barnette | Chief Scientific Officer | 2,300 | $5.08K |
| Grace Hyun | Director | 1,479 | $3.27K |
| Lucy Lu | Director | 980 | $2.17K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the VERU quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.